{
  "id": 3779,
  "text": "1801.Dodd, J.K., Henry, R.J., Tyler, J.P.& Houghton, C.R.Cervical carcinoma: a comparison of four potential biochemical tumor markers.Gynecol Oncol 32, 248-252 (1989).1802.Ngan, H.Y., Cheng, G.T., Yeung, W.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 1801.Dodd, J.K., Henry, R.J., Tyler, J.P.& Houghton, C.R.Cervical carcinoma: a comparison of four potential biochemical tumor markers.Gynecol Oncol 32, 248-252 (1989).1802.Ngan, H.Y., Cheng, G.T., Yeung, W.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "宫颈癌患者的生化肿瘤标志物有多种选择，其中一些常见的标志物包括鳞状上皮细胞癌抗原（SCC），癌胚抗原（CEA），以及糖链抗原125（CA125）。这些标志物在临床上可以用于辅助诊断宫颈癌，也可用于评估治疗效果及监测病情变化。鳞状上皮细胞癌抗原在宫颈鳞状细胞癌中尤为常见，而癌胚抗原和糖链抗原125则可能在一些其他类型的宫颈癌中出现升高。通过检测这些标志物的水平变化，医师能够获得有关病程和治疗反应的重要信息，从而更好地制定治疗计划。",
  "query": "宫颈癌患者的生化肿瘤标志物有哪些可能的选择？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 宫颈癌患者的生化肿瘤标志物有哪些可能的选择？\n\n<reference text>: 1801.Dodd, J.K., Henry, R.J., Tyler, J.P.& Houghton, C.R.Cervical carcinoma: a comparison of four potential biochemical tumor markers.Gynecol Oncol 32, 248-252 (1989).1802.Ngan, H.Y., Cheng, G.T., Yeung, W.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "宫颈癌患者的生化肿瘤标志物有多种选择，其中一些常见的标志物包括鳞状上皮细胞癌抗原（SCC），癌胚抗原（CEA），以及糖链抗原125（CA125）。这些标志物在临床上可以用于辅助诊断宫颈癌，也可用于评估治疗效果及监测病情变化。鳞状上皮细胞癌抗原在宫颈鳞状细胞癌中尤为常见，而癌胚抗原和糖链抗原125则可能在一些其他类型的宫颈癌中出现升高。通过检测这些标志物的水平变化，医师能够获得有关病程和治疗反应的重要信息，从而更好地制定治疗计划。"
}